Heron Therapeutics | HRTX - Ebitda





Ebitda Değişiklik Tarih
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Eisai JPY -335M 30.43B 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Veracyte USD 43.96M 1.16M 2026-06
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03